The modified live canine parvovirus (CPV) vaccine was used to vaccinate intranasally twenty‐five pups with maternal antibody. The vaccine was able to overcome the interference of maternal immunity in rates of 100 %, 72.7 % and 17.6 % in pups with haemagglutination inhibition antibody titre of 40, 80 and 160 respectively. © 1994 Blackwell Verlag GmbH
Intranasal vaccination of pups with maternally derived antibodies with a modified live canine parvovirus
BUONAVOGLIA, Canio;CAVALLI, Alessandra;VOIGT, Valentina;BUONAVOGLIA, Domenico;DE CAPRARIIS, Donato;
1994-01-01
Abstract
The modified live canine parvovirus (CPV) vaccine was used to vaccinate intranasally twenty‐five pups with maternal antibody. The vaccine was able to overcome the interference of maternal immunity in rates of 100 %, 72.7 % and 17.6 % in pups with haemagglutination inhibition antibody titre of 40, 80 and 160 respectively. © 1994 Blackwell Verlag GmbHFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
